Idera Pharmaceuticals files $200M mixed securities shelf
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
IDRA
Idera Pharmaceuticals files $200M mixed securities shelf
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Idera Pharmaceuticals files $200M mixed security shelf
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Why Idera Pharmaceuticals, Inc. Shares Slipped From a Huge Pop Today
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
8:32 am Idera Pharma announces agreement with Abbott (ABT) to develop a companion diagnostic for imo-8400 in genetically defined forms of b-cell lymphoma
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Idera Announces Agreement with Abbott to Develop a Companion Diagnostic for IMO-8400 in Genetically Defined Forms of B-cell Lymphoma
[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Idera Pharmaceuticals to Host Conference Call and Webcast to Report First Quarter 2014 Financial Results and Provide a Detailed Pipeline Review
[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune diseases, today announced that the Company will host a conference moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Idera Expands Management Team with Three Key Hires
[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune diseases, today announced the addition of three new management te moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
4:06 pm Idera Pharma presents preclinical data at AACR Showing IMO-8400 inhibits tumor growth and survival signaling in B-cell lymphoma cells with oncogenic MYD88 L265P mutation
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
